Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Federico C, Alhallak K, Sun J, Duncan K, Azab F, Sudlow GP, de la Puente P, Muz B, Kapoor V, Zhang L, Yuan F, Markovic M, Kotsybar J, Wasden K, Guenthner N, Gurley S, King J, Kohnen D, Salama NN, Thotala D, Hallahan DE, Vij R, DiPersio JF, Achilefu S, Azab AK.
Federico C, et al. Among authors: de la puente p.
Nat Commun. 2020 Nov 27;11(1):6037. doi: 10.1038/s41467-020-19932-1.
Nat Commun. 2020.
PMID: 33247158
Free PMC article.